Canaccord Genuity Starts Chembio Diagnostics (CEMI) at Buy
Tweet
Share
E-mailGet Alerts CEMI Hot Sheet
Price: $0.46 --0%
Rating Summary:
1 Buy, 4 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 4 | Down: 7 | New: 3
Rating Summary:
1 Buy, 4 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 4 | Down: 7 | New: 3
Join SI Premium – FREE
Canaccord Genuity analyst Mark Massaro initiates coverage on Chembio Diagnostics (NASDAQ: CEMI) with a Buy rating and a price target of $9.00.
For an analyst ratings summary and ratings history on Chembio Diagnostics click here. For more ratings news on Chembio Diagnostics click here.
Shares of Chembio Diagnostics closed at $5.48 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- JPMorgan Assumes Bravura Solutions Ltd (BVS:AU) at Neutral
- Morgan Stanley Starts Achieve Life Sciences (ACHV) at Overweight
- JPMorgan Starts Neway Valve Suzhou Co Ltd (603699:CH) at Overweight
Create E-mail Alert Related Categories
Hot New Coverage, New CoverageRelated Entities
Canaccord GenuitySign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
